The recent New York Times report detailing an alleged extramarital relationship between NVIDIA VP of healthcare Kimberly Powell and then-CEO Jensen Huang has intensified scrutiny on her position, coinciding with Huang’s abrupt resignation on November 12 amid separate investigations into misconduct and foreign influence concerns. Powell, who joined the company in 2008 and oversees AI-driven platforms for medical imaging, life sciences, and drug discovery, has not issued any public statement or announced her departure, and reports indicate no confirmed removal or suspension as of November 13. Trader sentiment reflects uncertainty over whether NVIDIA’s board will pursue internal reviews or leadership realignments that could affect direct reports like Powell, especially given the company’s code of conduct on conflicts of interest. Key near-term catalysts include any board announcements on executive transitions or formal responses to the allegations.